Welcome to our dedicated page for Cosmos Health news (Ticker: COSM), a resource for investors and traders seeking the latest updates and insights on Cosmos Health stock.
Cosmos Health Inc, also known as Cosmos Health, is a global healthcare group engaged in innovative R&D, pharmaceuticals & nutraceuticals manufacturing, and healthcare product distribution. The company owns proprietary brands like Sky Premium Life and Mediterranation, providing a wide range of products to healthcare providers. In recent news, the acquisition of Pelofarm's pharmacy distribution network in Greece shows Cosmos Health's strategic expansion and revenue growth.
Rhea-AI Summary
Cosmos Health, a global healthcare group, received a notification from Nasdaq for the late filing of its Form 10-K. The company is currently non-compliant with Nasdaq Listing Rule 5250(c)(1) but has 60 days to submit a plan to regain compliance. The CEO is optimistic about resolving the issue.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.45%
Tags
-
Rhea-AI Summary
Cosmos Health Inc. announces the development of Cloudscreen 2.0, an advanced AI drug repurposing platform, following the acquisition of Cloudscreen. The new platform utilizes cutting-edge AI and machine learning technologies to predict drug-protein interactions across the human proteome's structural landscape. By integrating mutagenesis data and prediction tools for disordered proteins, Cloudscreen 2.0 aims to revolutionize drug repurposing with more robust predictions and higher confidence scores. Greg Siokas, CEO of Cosmos Health, anticipates significant positive outcomes from Cloudscreen 2.0.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.73%
Tags
-
Rhea-AI Summary
Cosmos Health Inc. announces final stages of securing regulatory approval to sell biocide disinfectant hand soap, C-Scrub Wash 4% CHG, in the UK. The Company expects to enter agreements to supply the NHS, targeting a significant market share. C-Scrub offers immediate and prolonged antimicrobial action, catering to a wide range of microbes, with a focus on skin health and cosmetic friendliness. The global hospital disinfectant market is projected to grow significantly, positioning Cosmos Health for potential growth opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.57%
Tags
Rhea-AI Summary
Cosmos Health Inc. has received regulatory approval to sell its Sky Premium Life vitamins and food supplements in the UAE market, with a projected market growth to $3.94 billion by 2030. The company aims to secure an exclusive distribution agreement and increase revenue through expansion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.27%
Tags
-
Rhea-AI Summary
Cosmos Health Inc. announces the successful acquisition of Pharmatrade S.A.'s distribution network, aiming to boost 2024 revenue by $5 million and improve operational efficiencies through synergies with CosmoFarm Pharmaceuticals S.A.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.39%
Tags
-
Rhea-AI Summary
Cosmos Health Inc. receives a Speculative Buy rating and a $4.00 price target from Taglich Brothers, indicating substantial growth potential. The company's revenue is expected to reach $64 million in FY 2024, with a focus on vertical integration and global expansion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.12%
Tags
Rhea-AI Summary
Cosmos Health Inc. CEO, Mr. Greg Siokas, demonstrates his confidence in the company by acquiring 60,000 shares at $0.8301 each, totaling $49,806. Siokas plans to invest up to $3 million in shares by 2024. Despite significant company progress, Siokas believes the stock is undervalued, emphasizing commitment to enhancing shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.36%
Tags
-
Rhea-AI Summary
Cosmos Health Inc. announced that Taglich Brothers, Inc. has initiated coverage of the Company's common stock. Taglich Brothers is a full-service broker dealer with a focus on microcap companies. The coverage and associated reports will be available at www.taglichbrothers.com. Cosmos Health CEO, Greg Siokas, stated that the company has accomplished multiple milestones, including transforming its balance sheet, completing strategic acquisitions, enhancing production facilities, launching new brands, filing patent applications, and establishing a portfolio of generic drugs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.5%
Tags
-
Rhea-AI Summary
Cosmos Health Inc. has successfully completed the acquisition of Cloudscreen, a cutting-edge AI-powered platform specialized in drug repurposing. Cloudscreen's AI algorithm integrates 1D and 3D data to provide accurate predictions for existing drugs towards new indications, offering higher success rates, heightened safety profiles, and significantly shorter impact times compared to traditional drug development.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.96%
Tags
Rhea-AI Summary
Cosmos Health Inc. has completed the acquisition of a portfolio of 10 generic drugs, enhancing its pharmaceutical portfolio. The acquisition cost €3.2 million, and the global generic drugs market is projected to reach $613.34 billion by 2030. Cosmos Health aims to capture a substantial share of this market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.75%
Tags
FAQ
What is the current stock price of Cosmos Health (COSM)?
The current stock price of Cosmos Health (COSM) is $0.6165 as of February 21, 2025.
What is the market cap of Cosmos Health (COSM)?
The market cap of Cosmos Health (COSM) is approximately 14.6M.
What is Cosmos Health Inc known for?
Cosmos Health Inc is a global healthcare group engaged in R&D, pharmaceuticals & nutraceuticals manufacturing, and healthcare product distribution.
What proprietary brands does Cosmos Health Inc own?
Cosmos Health Inc owns proprietary brands like Sky Premium Life and Mediterranation.
What recent development has Cosmos Health Inc made?
Recent news includes the acquisition of Pelofarm's pharmacy distribution network in Greece, showcasing strategic expansion and revenue growth.
Where does Cosmos Health Inc operate?
Cosmos Health Inc is currently expanding throughout Europe, Asia, and North America, with offices and distribution centers in Thessaloniki, Athens, and Harlow.
How is Cosmos Health Inc leveraging technology in its operations?
Cosmos Health Inc utilizes advanced technological systems like A-Frame and ROWA in its facilities for automated procurement, inventory management, and order execution.
Cosmos Health Inc.
Nasdaq:COSM
COSM Rankings
COSM Stock Data
14.62M
18.81M
15.51%
10.28%
1.56%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
United States
THESSALONIKI